Penwest Pharmaceuticals has signed its fourth R&D agreement with Otsuka Pharmaceutical of Japan for Penwest to develop a formulation of an undisclosed Otsuka compound utilizing Penwest's TIMERx drug delivery technology.
Penwest signs R&D agreement with Otsuka Pharmaceutical